Clarivate Completes US$2.25B Equity Offering
Press releases | June 14, 2021
Fried Frank acted as counsel to the underwriters in connection with Clarivate Plc’s US$1 billion registered primary offering of 28,846,154 ordinary shares and secondary offering of 9,615,384 ordinary shares by certain affiliated funds of Onex Partners Advisors LLC and Baring Private Equity Asia Pte Ltd, totaling 38,461,538 ordinary shares. In addition, the underwriters were granted, pursuant to an over-allotment option, the option to purchase up to 5,769,230 ordinary shares were granted to the underwriters pursuant to an over-allotment option. The over-allotment option was exercised in full on June 10, 2021. Additionally, Fried Frank acted as counsel to the underwriters in connection with Clarivate Plc’s US$1.25 billion registered primary offering of 12,500,000 5.25% Series A Mandatory Convertible Preferred Shares. In addition, the underwriters were granted, pursuant to an over-allotment option, the option to purchase up to an additional 1,875,000 convertible preferred shares solely to cover over-allotments. The over-allotment option was exercised in full on June 10, 2021. Clarivate is a leader in providing trusted insights and analytics to the scientific research, intellectual property, and life sciences end-markets.
The Fried Frank team was led by corporate partners Daniel J. Bursky and Meredith L. Mackey, and included corporate partners Mark Hayek and Ezra Schneck; tax partner Joseph E. Fox; corporate special counsel Matthew I. Levy; tax special counsel Ryan L. Conley; and corporate associates Marie Kwon, Benjamin Whitman, Tiana Cherry, and Adam Picker.
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.